Search by Drug Name or NDC

    NDC 60760-0654-10 Ondansetron 4 mg/1 Details

    Ondansetron 4 mg/1

    Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ST. MARY'S MEDICAL PARK PHARMACY. The primary component is ONDANSETRON.

    Product Information

    NDC 60760-0654
    Product ID 60760-654_f1759d52-c768-6f81-e053-2995a90aecf2
    Associated GPIs
    GCN Sequence Number 041562
    GCN Sequence Number Description ondansetron TAB RAPDIS 4 MG ORAL
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 20045
    HICL Sequence Number 019058
    HICL Sequence Number Description ONDANSETRON
    Brand/Generic Generic
    Proprietary Name Ondansetron
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ondansetron
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name ONDANSETRON
    Labeler Name ST. MARY'S MEDICAL PARK PHARMACY
    Pharmaceutical Class Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078152
    Listing Certified Through 2024-12-31

    Package

    NDC 60760-0654-10 (60760065410)

    NDC Package Code 60760-654-10
    Billing NDC 60760065410
    Package 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (60760-654-10)
    Marketing Start Date 2022-12-22
    NDC Exclude Flag N
    Pricing Information N/A